171 related articles for article (PubMed ID: 33995370)
1. Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome.
Padeira GL; Araújo C; Cordeiro AI; Freixo J; Martins CG; Neves JF
Front Immunol; 2021; 12():654167. PubMed ID: 33995370
[TBL] [Abstract][Full Text] [Related]
2. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S; Winter S
Front Immunol; 2018; 9():1103. PubMed ID: 29942301
[TBL] [Abstract][Full Text] [Related]
3. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
Worth AJ; Houldcroft CJ; Booth C
Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
[TBL] [Abstract][Full Text] [Related]
5. NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.
Boztug H; Hirschmugl T; Holter W; Lakatos K; Kager L; Trapin D; Pickl W; Förster-Waldl E; Boztug K
J Clin Immunol; 2016 Aug; 36(6):533-40. PubMed ID: 27338827
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S; Fischer A
Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
[TBL] [Abstract][Full Text] [Related]
7. Non-uniform
Burns DM; Ryan GB; Harvey CM; Nagy E; Hughes S; Murray PG; Russell NH; Fox CP; Long HM
Front Immunol; 2019; 10():2489. PubMed ID: 31736946
[TBL] [Abstract][Full Text] [Related]
8. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.
Zheng X; Xie J; Zhou X
Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus in patients with immunodeficiency disorders.
Okano M
Biomed Pharmacother; 2001 Sep; 55(7):353-61. PubMed ID: 11669496
[TBL] [Abstract][Full Text] [Related]
12. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.
Smets F; Latinne D; Bazin H; Reding R; Otte JB; Buts JP; Sokal EM
Transplantation; 2002 May; 73(10):1603-10. PubMed ID: 12042647
[TBL] [Abstract][Full Text] [Related]
13. Association between HLA-A1 and -A2 types and Epstein-Barr virus status of post-transplant lymphoproliferative disorder.
Kinch A; Sundström C; Tufveson G; Glimelius I
Leuk Lymphoma; 2016 Oct; 57(10):2351-8. PubMed ID: 27104753
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system vasculitis from Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children: A case report.
Lee MS; Hwang SK; Kim YE; Suh JK; Kim H; Lee SM; Jeong JY; Kwon S; Lee YJ
Brain Dev; 2019 Oct; 41(9):820-825. PubMed ID: 31208818
[TBL] [Abstract][Full Text] [Related]
15. A case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder.
Cho HS; Kim IS; Park HC; Ahn MJ; Lee YY; Park CK
Korean J Intern Med; 2004 Jun; 19(2):124-7. PubMed ID: 15366645
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
Cai Q; Chen K; Young KH
Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
18. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Kuno M; Ito A; Maeshima AM; Taniguchi H; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
Int J Hematol; 2020 Aug; 112(2):193-199. PubMed ID: 32472530
[TBL] [Abstract][Full Text] [Related]
19. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
20. Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy.
Kim DH; Kim M; Kim Y; Han K; Han E; Lee JW; Chung NG; Cho B
J Pediatr Hematol Oncol; 2017 Nov; 39(8):e497-e500. PubMed ID: 28697169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
